Valuation: ATTANA AB

Market Cap 7.74M 803K 702K 648K 597K 1.13M 77.35M 1.15M 3.05M 37.88M 3.02M 2.95M 130M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 788K 689K 636K 586K 1.1M 75.9M 1.13M 2.99M 37.17M 2.96M 2.89M 128M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/04/2025
Chief Executive Officer 56 01/09/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 01/10/2015
Director/Board Member 56 06/08/2012
Director/Board Member 62 01/01/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 803K
-2.93%+4.62%-36.01%-43.42% 640M
-9.12%+31.92%+179.80% - 515M
-4.31%-7.63%-41.84%+21.16% 114M
0.00%-5.08%+17.15%+70.73% 108M
Average -3.27%+5.96%+29.78%+16.16% 344.15M
Weighted average by Cap. -5.13%+13.06%+48.35%-20.64%

Financials

2024 2025
Net sales 6.61M 686K 600K 553K 510K 961K 66.08M 983K 2.6M 32.36M 2.58M 2.52M 111M 4.01M 416K 363K 335K 309K 583K 40.04M 595K 1.58M 19.61M 1.56M 1.53M 67.51M
Net income -12.78M -1.33M -1.16M -1.07M -985K -1.86M -128M -1.9M -5.03M -62.52M -4.98M -4.87M -215M -10.5M -1.09M -952K -879K -810K -1.53M -105M -1.56M -4.13M -51.39M -4.09M -4M -177M
Net Debt 1.17M 121K 106K 97.97K 90.3K 170K 11.7M 174K 461K 5.73M 456K 446K 19.72M -145K -15.09K -13.19K -12.17K -11.22K -21.14K -1.45M -21.61K -57.2K -712K -56.67K -55.42K -2.45M
Logo ATTANA AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
-